The role of the protocol biopsies in renal allograft recipients

Transplantation Proceedings

Volumn 35, Issue 6, 2003, Pages 2179-2181

  Baczkowska, T ^a   Perkowska Francka, A ^a   Durlik, M ^a   Cieciura, T ^a   Nowacka Cieciura, E ^a   Pazik, J ^a   Lewandowska, D ^a   Mroz, A ^a   Matlosz, B ^a   Chmura, A ^a   Galazka, Z ^a   Lao, M ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; CREATININE; CYCLOSPORIN A; DACLIZUMAB; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PLATELET DERIVED GROWTH FACTOR BB; PREDNISOLONE; TRANSFORMING GROWTH FACTOR BETA;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIAGNOSTIC TEST; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; FUNCTIONAL ASSESSMENT; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; KIDNEY GRAFT REJECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RECIPIENT; TREATMENT OUTCOME;

EID: 10744229742     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0041-1345(03)00807-8     Document Type: Conference Paper

References (7)

1. Schwarz A., Mengel M., Gwinner W., et al. Transplant Proc. 34:2002;2238.
2. Isoniemi H. Transplant Proc. 34:2002;1713.
3. Veronese F.V., Noronha I.L., Manfro R.C., et al. Transplant Proc. 34:2002;500.
4. Keunecke C., Rothenpieler U., Zanker B., et al. Transplant Proc. 32:(suppl 1A):2000;6S.
5. Abramowicz D., Manas D., Lao M., et al. Transplantation. 74:2002;1725.
6. Vincenti F., Grinyo J., Ramos E., et al. Transplant Proc. 31:1999;1246.
7. Nashan B. Transplant Proc. 31:(suppl 8A):1999;23S.